Svend O. Freytag

6.5k total citations
83 papers, 5.4k citations indexed

About

Svend O. Freytag is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Svend O. Freytag has authored 83 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 50 papers in Genetics and 27 papers in Oncology. Recurrent topics in Svend O. Freytag's work include Virus-based gene therapy research (48 papers), CAR-T cell therapy research (20 papers) and Cancer Research and Treatments (18 papers). Svend O. Freytag is often cited by papers focused on Virus-based gene therapy research (48 papers), CAR-T cell therapy research (20 papers) and Cancer Research and Treatments (18 papers). Svend O. Freytag collaborates with scholars based in United States, United Kingdom and Germany. Svend O. Freytag's co-authors include Dell Paielli, Jeff D. Gilbert, Jae Ho Kim, Kenneth Rogulski, Graham LeM. Campbell, Gudrun S. Bennett, Richard P. Shank, Hans Stricker, Mei Lü and Stephen L. Brown and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Svend O. Freytag

83 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svend O. Freytag United States 41 3.3k 2.4k 1.6k 790 523 83 5.4k
Arthur Sands United States 35 4.0k 1.2× 1.1k 0.5× 2.1k 1.3× 298 0.4× 427 0.8× 62 6.5k
Jeffrey E. Kudlow United States 51 5.6k 1.7× 887 0.4× 1.1k 0.7× 139 0.2× 458 0.9× 97 7.5k
Maria Laura Avantaggiati United States 34 3.0k 0.9× 473 0.2× 1.5k 0.9× 177 0.2× 298 0.6× 64 4.5k
José C. Perales Spain 30 2.7k 0.8× 837 0.3× 606 0.4× 104 0.1× 463 0.9× 72 4.3k
Srikumar Chellappan United States 46 5.5k 1.6× 952 0.4× 3.4k 2.1× 188 0.2× 355 0.7× 108 7.9k
Vjekoslav Dulić France 28 5.5k 1.6× 588 0.2× 4.2k 2.6× 563 0.7× 1.1k 2.2× 41 7.7k
Makoto Nakanishi Japan 49 6.4k 1.9× 731 0.3× 2.7k 1.7× 167 0.2× 664 1.3× 195 9.1k
Paolo Salomoni United Kingdom 45 4.8k 1.4× 527 0.2× 1.4k 0.9× 155 0.2× 368 0.7× 104 6.5k
W. Kruijer Netherlands 46 4.8k 1.4× 1.2k 0.5× 1.8k 1.2× 125 0.2× 525 1.0× 95 7.4k
Youngkyu Park South Korea 35 2.9k 0.9× 618 0.3× 1.4k 0.9× 180 0.2× 289 0.6× 88 5.0k

Countries citing papers authored by Svend O. Freytag

Since Specialization
Citations

This map shows the geographic impact of Svend O. Freytag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svend O. Freytag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svend O. Freytag more than expected).

Fields of papers citing papers by Svend O. Freytag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svend O. Freytag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svend O. Freytag. The network helps show where Svend O. Freytag may publish in the future.

Co-authorship network of co-authors of Svend O. Freytag

This figure shows the co-authorship network connecting the top 25 collaborators of Svend O. Freytag. A scholar is included among the top collaborators of Svend O. Freytag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svend O. Freytag. Svend O. Freytag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freytag, Svend O., Stephen L. Brown, Jae Ho Kim, et al.. (2023). Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health. SHILAP Revista de lepidopterología. 8(1). 11–11. 16 indexed citations
2.
Nyati, Shyam, Hans Stricker, Kenneth Barton, et al.. (2023). A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma. PLoS ONE. 18(9). e0291315–e0291315. 13 indexed citations
3.
Barton, Kenneth, Farzan Siddiqui, Svend O. Freytag, et al.. (2020). Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer. Molecular Therapy — Oncolytics. 20. 94–104. 43 indexed citations
4.
Gibson, Heather M., Svend O. Freytag, Kenneth Barton, et al.. (2015). Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors. OncoImmunology. 4(1). e984523–e984523. 11 indexed citations
5.
Kumar, Sanath, Svend O. Freytag, Kenneth Barton, et al.. (2010). A Novel Method of Boron Delivery Using Sodium Iodide Symporter for Boron Neutron Capture Therapy. Journal of Radiation Research. 51(5). 621–626. 1 indexed citations
6.
Siddiqui, Farzan, Andrew Kolozsvary, Kenneth Barton, et al.. (2009). Does hyperthermia increase adenoviral transgene expression or dissemination in tumors?. International Journal of Hyperthermia. 25(4). 273–279. 3 indexed citations
7.
Kumar, Sanath, et al.. (2008). Efficacy of suicide gene therapy in hypoxic rat 9L glioma cells. Journal of Neuro-Oncology. 90(1). 19–24. 4 indexed citations
8.
Yan, Shiqing, Stephen L. Brown, Andrew Kolozsvary, et al.. (2008). Mitigation of radiation‐induced skin injury by AAV2‐mediated MnSOD gene therapy. The Journal of Gene Medicine. 10(9). 1012–1018. 31 indexed citations
9.
Barton, Kenneth, Svend O. Freytag, T Nurushev, et al.. (2007). A Model for Optimizing Adenoviral Delivery in Human Cancer Gene Therapy Trials. Human Gene Therapy. 18(6). 562–572. 4 indexed citations
10.
Brown, Stephen L., Svend O. Freytag, Kenneth Barton, et al.. (2007). Reporter gene imaging using radiographic contrast from nonradioactive iodide sequestered by the sodium–iodide symporter. Contrast Media & Molecular Imaging. 2(5). 240–247. 4 indexed citations
11.
Freytag, Svend O., Kenneth Barton, Stephen L. Brown, et al.. (2007). Replication-competent Adenovirus-mediated Suicide Gene Therapy with Radiation in a Preclinical Model of Pancreatic Cancer. Molecular Therapy. 15(9). 1600–1606. 52 indexed citations
12.
13.
Freytag, Svend O., Jae Ho Kim, Stephen L. Brown, et al.. (2004). Gene therapy strategies to improve the effectiveness of cancer radiotherapy. Expert Opinion on Biological Therapy. 4(11). 1757–1770. 13 indexed citations
14.
Barton, Kenneth, Hans Stricker, Sweaty Koul, et al.. (2003). GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. Molecular Therapy. 8(3). 508–518. 63 indexed citations
15.
16.
Gautam, S.C., et al.. (1998). Antileukemic Activity of TNF-α Therapy with Myeloid Progenitor Cells Against Minimal Leukemia. Journal of Hematotherapy. 7(2). 115–125. 6 indexed citations
17.
Rogulski, Kenneth, Jae Ho Kim, Sang Hie Kim, & Svend O. Freytag. (1997). Glioma Cells Transduced with an Escherichia coli CD/HSV-1 TK Fusion Gene Exhibit Enhanced Metabolic Suicide and Radiosensitivity. Human Gene Therapy. 8(1). 73–85. 130 indexed citations
18.
Geddes, Timothy J., et al.. (1995). Murine collagen intron-binding factor I (CIBF-I) is the same protein as transcription factor Oct-1. Gene. 158(2). 231–235. 1 indexed citations
19.
Freytag, Svend O., Dell Paielli, & Jeff D. Gilbert. (1994). Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells.. Genes & Development. 8(14). 1654–1663. 392 indexed citations
20.
Freytag, Svend O., H G Bock, Arthur L. Beaudet, & W E O'Brien. (1984). Molecular structures of human argininosuccinate synthetase pseudogenes. Evolutionary and mechanistic implications.. Journal of Biological Chemistry. 259(5). 3160–3166. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur Sands Breakdown of academic impact, for papers by Jeffrey E. Kudlow Breakdown of academic impact, for papers by Maria Laura Avantaggiati Breakdown of academic impact, for papers by José C. Perales Breakdown of academic impact, for papers by Srikumar Chellappan Breakdown of academic impact, for papers by Vjekoslav Dulić Breakdown of academic impact, for papers by Makoto Nakanishi Breakdown of academic impact, for papers by Paolo Salomoni Breakdown of academic impact, for papers by W. Kruijer Breakdown of academic impact, for papers by Youngkyu Park
Rankless by CCL
2026